Investigating biomarkers in patients with acute pericarditis
Prognostic Biomarkers in Patients With Acute Pericarditis
This study is testing new blood and imaging markers in patients with acute pericarditis to see if they can help predict complications and recurrences of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Hippocration General Hospital Academic / other |
| Locations | 1 site (Athens, Attiki) |
| Trial ID | NCT02754713 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore novel plasma and imaging biomarkers in patients diagnosed with acute pericarditis. Participants will undergo blood sampling to measure potential biomarkers and will be followed for up to 18 months to assess the prognostic value of these biomarkers in predicting complications such as atrial fibrillation and pericarditis recurrences. The study will include 300 patients and will adhere to established clinical recommendations for diagnosis and treatment.
Who should consider this trial
Good fit: Ideal candidates are individuals with a first diagnosis of acute pericarditis.
Not a fit: Patients who are unwilling to provide written consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved risk stratification and management of patients with acute pericarditis.
How similar studies have performed: While there is limited clinical evidence on prognostic factors in acute pericarditis, this study's focus on novel biomarkers represents a potentially novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with first diagnosis of acute pericarditis Exclusion Criteria: * Not willing to provide written consent
Where this trial is running
Athens, Attiki
- Cardiology Department, Hippokration Hospital — Athens, Attiki, Greece (Recruiting)
Study contacts
- Study coordinator: George Lazaros
- Email: glaz35@hotmail.com
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.